Evaluation of in vivo antibacterial drug efficacy using Caenorhabditis elegans infected with carbapenem-resistant Klebsiella pneumoniae as a model host

Objective: This study was developed to assess the in vivo antimicrobial activity of specific drugs using a model system consisting of Caenorhabditis elegans (C. elegans) infected with Carbapenem-resistant Klebsiella pneumoniae (CRKP) in an effort to identify promising drugs for CRKP-infected patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Huijuan, Xu, Ajing, Liu, Jingxian, Wang, Fang, Yao, Huimin, Chen, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439659/
https://www.ncbi.nlm.nih.gov/pubmed/36059996
http://dx.doi.org/10.3389/fphar.2022.973551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439659/
https://www.ncbi.nlm.nih.gov/pubmed/36059996
http://dx.doi.org/10.3389/fphar.2022.973551

Ejemplares similares